The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
about
Identification of H2N3 influenza A viruses from swine in the United StatesOptimal Use of Vaccines for Control of Influenza A Virus in SwineMathematical modeling of influenza A virus dynamics within swine farms and the effects of vaccinationHarnessing Local Immunity for an Effective Universal Swine Influenza VaccineInfluenza A virus PB1-F2 protein expression is regulated in a strain-specific manner by sequences located downstream of the PB1-F2 initiation codon.Swine influenza virus vaccine serologic cross-reactivity to contemporary US swine H3N2 and efficacy in pigs infected with an H3N2 similar to 2011-2012 H3N2v.Distribution of antibodies against influenza virus in pigs from farrow-to-finish farms in Minas Gerais state, Brazil.Replication and transmission of mammalian-adapted H9 subtype influenza virus in pigs and quailHeterologous challenge in the presence of maternally-derived antibodies results in vaccine-associated enhanced respiratory disease in weaned piglets.Age at Vaccination and Timing of Infection Do Not Alter Vaccine-Associated Enhanced Respiratory Disease in Influenza A Virus-Infected Pigs.Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs.Pandemic (H1N1) 2009 virus on commercial swine farm, Thailand.Brief report: Molecular characterization of a novel reassorted pandemic H1N1 2009 in Thai pigs.Single-step multiplex reverse transcription polymerase chain reaction assay for detection and differentiation of the 2009 H1N1 Influenza A virus pandemic in Thai swine populations.Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus.Pathogenicity and transmission in pigs of the novel A(H3N2)v influenza virus isolated from humans and characterization of swine H3N2 viruses isolated in 2010-2011.Retrospective swine influenza serological surveillance in the four highest pig density provinces of Thailand before the introduction of the 2009 pandemic Influenza A virus subtype H1N1 using various antibody detection assays.Vaccine development for protecting swine against influenza virus.Comparative study of pandemic (H1N1) 2009, swine H1N1, and avian H3N2 influenza viral infections in quails.Infection dynamics of pandemic 2009 H1N1 influenza virus in a two-site swine herd.Comparison of protection against H5N1 influenza virus in mouse offspring provided by maternal vaccination with HA DNA and inactivated vaccine.Maternal immunity enhances Mycoplasma hyopneumoniae vaccination induced cell-mediated immune responses in pigletsEfficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine.Adverse effects of Influenza A(H1N1)pdm09 virus infection on growth performance of Norwegian pigs - a longitudinal study at a boar testing station.Intranasal Immunization of Mice to Avoid Interference of Maternal Antibody against H5N1 Infection.Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.Maternally Derived Immunity Extends Swine Influenza A Virus Persistence within Farrow-to-Finish Pig Farms: Insights from a Stochastic Event-Driven Metapopulation ModelComparison of Human-Like H1 (δ-Cluster) Influenza A Viruses in the Swine Host.Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease.Intranasal vaccination with replication-defective adenovirus type 5 encoding influenza virus hemagglutinin elicits protective immunity to homologous challenge and partial protection to heterologous challenge in pigs.In vivo evaluation of vaccine efficacy against challenge with a contemporary field isolate from the α cluster of H1N1 swine influenza virus.The impact of maternally derived immunity on influenza A virus transmission in neonatal pig populationsEfficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011-2012 H3N2v.Pathogenesis of swine influenza virus (Thai isolates) in weanling pigs: an experimental trial.Maternally-derived antibodies do not prevent transmission of swine influenza A virus between pigs.The Molecular Determinants of Antibody Recognition and Antigenic Drift in the H3 Hemagglutinin of Swine Influenza A Virus.Dynamics of influenza A virus infections in permanently infected pig farms: evidence of recurrent infections, circulation of several swine influenza viruses and reassortment events.Swine influenza vaccines: current status and future perspectives.Influenza A Virus Surveillance Based on Pre-Weaning Piglet Oral Fluid Samples.
P2860
Q24646263-C23CA78B-C059-44BB-A5B9-F57F334A187FQ26783503-35AB6EF9-42AF-4F5C-8D36-794F398BD46DQ27313553-4CE8329A-0B51-4861-A74F-25D3B8693C81Q30234558-CF57C799-1382-4012-BBDF-A951B7774128Q30352320-5108A6CC-98F8-405A-AA5E-5C81B6FF796CQ30355545-73364791-B1F0-48CD-9574-EE4F25BF3099Q30371413-2ECDA651-31F4-4AA4-8C62-E87E962822C9Q30374791-BD61A48B-AA21-4CEF-9F5B-A7BE01A0614FQ30384443-381174E3-6D1A-4465-971D-850D02CD840DQ30386279-DD637BD0-F3B6-459F-957F-58424DB7F5E7Q30388012-1874DA80-3513-497D-867B-ABEDE5855C51Q30388390-7B80375B-06AA-4AE9-854C-504248028110Q30394176-275C1E8D-5175-474C-A62B-51D0129BF16AQ30401211-4D6C1409-8717-4FFA-9F11-53269DF2DBABQ30406952-436C24E2-93FD-4E24-941E-C4DBD723259CQ30414781-A2ACBDEA-0F57-43A6-9365-1F31E076811DQ30415221-B2255AB8-A642-4836-A62E-A5BF82FFC37CQ30423807-02E5BFEE-B8AC-4FDC-9AF0-883BD9B301B3Q30424943-14D52C48-3AAC-42B9-B51C-DAE167732E63Q30425166-A8DC10B0-2DE8-497F-9200-9B488EF62C04Q30425569-946B5C43-C5DB-4CCE-98A4-582B3E0721FBQ30426825-AD144125-7581-4871-8366-B6AC4E37A2CBQ33786314-B044078F-FE82-4633-8976-E873315A2323Q34700580-D0135BC5-B2BB-4031-B27B-9AD6F63EE8D7Q34990924-9EDAB116-22FF-481C-8B3F-41DAC052E786Q36046358-0225EE1C-A381-4130-8F41-291D20B988AFQ36087562-0D321703-8910-4FBE-9130-2D8C6E3BD993Q36143152-03E5902D-CEF1-4879-A1EB-C78D84238059Q36248252-1EC0C4B0-441E-4C9F-84DB-8AA57F11F6FCQ36276647-4713D6A8-543D-4B6A-BB9D-8DFE080379D8Q36378581-5DA1F6AB-BBB2-4129-8F78-A92A26A3F397Q36475009-ABD3452A-C30C-4F90-8393-A7CB2B00BF76Q36501567-03359EAF-E02B-4027-A704-0DF34D4AC063Q37123473-33B50026-EBD6-4AA3-83B5-EB9B373BED20Q37182114-FE6F8495-0943-4214-9450-CD186A4BF5A4Q37182410-EFD6E517-2CD8-4BA4-B347-6BB034B5546CQ37224897-29730DD6-34DD-4542-B4B6-1EEB0CCB48B1Q37355374-CA43114C-55E2-42A0-9285-859EF39B7854Q37749889-6E081005-F3B5-425D-973A-542CE5B16CA8Q39079474-39E888CF-53C7-47C1-9553-ACAE02974385
P2860
The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The immune response and matern ...... fection following vaccination.
@en
type
label
The immune response and matern ...... fection following vaccination.
@en
prefLabel
The immune response and matern ...... fection following vaccination.
@en
P2093
P1476
The immune response and matern ...... fection following vaccination.
@en
P2093
Barbara J Erickson
Bruce H Janke
Dachrit Nilubol
Eileen L Thacker
Pravina Kitikoon
Steve A Sornsen
Thayer C Hoover
P304
P356
10.1016/J.VETIMM.2006.02.008
P577
2006-04-18T00:00:00Z